Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Non-Current Deferred Tax Liability: 2017-2023

Historic Non-Current Deferred Tax Liability for Aclaris Therapeutics (ACRS) over the last 6 years, with Sep 2023 value amounting to $367,000.

  • Aclaris Therapeutics' Non-Current Deferred Tax Liability changed negligibly% to $367,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $367,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $367,000 for FY2022, which is negligibly% changed negligibly from last year.
  • Per Aclaris Therapeutics' latest filing, its Non-Current Deferred Tax Liability stood at $367,000 for Q3 2023, which was down 0.00% from $367,000 recorded in Q2 2023.
  • In the past 5 years, Aclaris Therapeutics' Non-Current Deferred Tax Liability ranged from a high of $549,000 in Q1 2019 and a low of $367,000 during Q4 2020.
  • In the last 3 years, Aclaris Therapeutics' Non-Current Deferred Tax Liability had a median value of $367,000 in 2023 and averaged $367,000.
  • Data for Aclaris Therapeutics' Non-Current Deferred Tax Liability shows a maximum YoY crashed of 33.15% (in 2020) over the last 5 years.
  • Over the past 5 years, Aclaris Therapeutics' Non-Current Deferred Tax Liability (Quarterly) stood at $549,000 in 2019, then tumbled by 33.15% to $367,000 in 2020, then remained steady at $367,000 in 2021, then remained steady at $367,000 in 2022, then remained steady at $367,000 in 2023.
  • Its Non-Current Deferred Tax Liability was $367,000 in Q3 2023, compared to $367,000 in Q2 2023 and $367,000 in Q1 2023.